Beyond the semi-synthetic artemisinin: metabolic engineering of plant-derived anti-cancer drugs
{{output}}
The discovery and supply of plant-derived anti-cancer compounds remain challenging given their low bioavailability and structural complexity. Reconstituting the pathways of these compounds in heterologous hosts is a promising solution; however, requires the co... ...